OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis

Ann Vincent, Tanya L. Hoskin, Mary O. Whipple, Daniel J. Clauw, Debra L. Barton, Roberto P Benzo, David A. Williams

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Introduction: The aim of this study was to identify subsets of patients with fibromyalgia with similar symptom profiles using the Outcome Measures in Rheumatology (OMERACT) core symptom domains. Methods: Female patients with a diagnosis of fibromyalgia and currently meeting fibromyalgia research survey criteria completed the Brief Pain Inventory, the 30-item Profile of Mood States, the Medical Outcomes Sleep Scale, the Multidimensional Fatigue Inventory, the Multiple Ability Self-Report Questionnaire, the Fibromyalgia Impact Questionnaire-Revised (FIQ-R) and the Short Form-36 between 1 June 2011 and 31 October 2011. Hierarchical agglomerative clustering was used to identify subgroups of patients with similar symptom profiles. To validate the results from this sample, hierarchical agglomerative clustering was repeated in an external sample of female patients with fibromyalgia with similar inclusion criteria. Results: A total of 581 females with a mean age of 55.1 (range, 20.1 to 90.2) years were included. A four-cluster solution best fit the data, and each clustering variable differed significantly (P <0.0001) among the four clusters. The four clusters divided the sample into severity levels: Cluster 1 reflects the lowest average levels across all symptoms, and cluster 4 reflects the highest average levels. Clusters 2 and 3 capture moderate symptoms levels. Clusters 2 and 3 differed mainly in profiles of anxiety and depression, with Cluster 2 having lower levels of depression and anxiety than Cluster 3, despite higher levels of pain. The results of the cluster analysis of the external sample (n = 478) looked very similar to those found in the original cluster analysis, except for a slight difference in sleep problems. This was despite having patients in the validation sample who were significantly younger (P <0.0001) and had more severe symptoms (higher FIQ-R total scores (P = 0.0004)). Conclusions: In our study, we incorporated core OMERACT symptom domains, which allowed for clustering based on a comprehensive symptom profile. Although our exploratory cluster solution needs confirmation in a longitudinal study, this approach could provide a rationale to support the study of individualized clinical evaluation and intervention.

Original languageEnglish (US)
Article number463
JournalArthritis Research and Therapy
Volume16
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Fibromyalgia
Cluster Analysis
Sleep
Anxiety
Depression
Pain
Equipment and Supplies
Aptitude
Rheumatology
Self Report
Fatigue
Longitudinal Studies
Outcome Assessment (Health Care)
Surveys and Questionnaires
Research

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Vincent, A., Hoskin, T. L., Whipple, M. O., Clauw, D. J., Barton, D. L., Benzo, R. P., & Williams, D. A. (2014). OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis. Arthritis Research and Therapy, 16(1), [463]. https://doi.org/10.1186/s13075-014-0463-7

OMERACT-based fibromyalgia symptom subgroups : An exploratory cluster analysis. / Vincent, Ann; Hoskin, Tanya L.; Whipple, Mary O.; Clauw, Daniel J.; Barton, Debra L.; Benzo, Roberto P; Williams, David A.

In: Arthritis Research and Therapy, Vol. 16, No. 1, 463, 2014.

Research output: Contribution to journalArticle

Vincent, A, Hoskin, TL, Whipple, MO, Clauw, DJ, Barton, DL, Benzo, RP & Williams, DA 2014, 'OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis', Arthritis Research and Therapy, vol. 16, no. 1, 463. https://doi.org/10.1186/s13075-014-0463-7
Vincent, Ann ; Hoskin, Tanya L. ; Whipple, Mary O. ; Clauw, Daniel J. ; Barton, Debra L. ; Benzo, Roberto P ; Williams, David A. / OMERACT-based fibromyalgia symptom subgroups : An exploratory cluster analysis. In: Arthritis Research and Therapy. 2014 ; Vol. 16, No. 1.
@article{e7f3924dc4b846649a37e2dbd39256cc,
title = "OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis",
abstract = "Introduction: The aim of this study was to identify subsets of patients with fibromyalgia with similar symptom profiles using the Outcome Measures in Rheumatology (OMERACT) core symptom domains. Methods: Female patients with a diagnosis of fibromyalgia and currently meeting fibromyalgia research survey criteria completed the Brief Pain Inventory, the 30-item Profile of Mood States, the Medical Outcomes Sleep Scale, the Multidimensional Fatigue Inventory, the Multiple Ability Self-Report Questionnaire, the Fibromyalgia Impact Questionnaire-Revised (FIQ-R) and the Short Form-36 between 1 June 2011 and 31 October 2011. Hierarchical agglomerative clustering was used to identify subgroups of patients with similar symptom profiles. To validate the results from this sample, hierarchical agglomerative clustering was repeated in an external sample of female patients with fibromyalgia with similar inclusion criteria. Results: A total of 581 females with a mean age of 55.1 (range, 20.1 to 90.2) years were included. A four-cluster solution best fit the data, and each clustering variable differed significantly (P <0.0001) among the four clusters. The four clusters divided the sample into severity levels: Cluster 1 reflects the lowest average levels across all symptoms, and cluster 4 reflects the highest average levels. Clusters 2 and 3 capture moderate symptoms levels. Clusters 2 and 3 differed mainly in profiles of anxiety and depression, with Cluster 2 having lower levels of depression and anxiety than Cluster 3, despite higher levels of pain. The results of the cluster analysis of the external sample (n = 478) looked very similar to those found in the original cluster analysis, except for a slight difference in sleep problems. This was despite having patients in the validation sample who were significantly younger (P <0.0001) and had more severe symptoms (higher FIQ-R total scores (P = 0.0004)). Conclusions: In our study, we incorporated core OMERACT symptom domains, which allowed for clustering based on a comprehensive symptom profile. Although our exploratory cluster solution needs confirmation in a longitudinal study, this approach could provide a rationale to support the study of individualized clinical evaluation and intervention.",
author = "Ann Vincent and Hoskin, {Tanya L.} and Whipple, {Mary O.} and Clauw, {Daniel J.} and Barton, {Debra L.} and Benzo, {Roberto P} and Williams, {David A.}",
year = "2014",
doi = "10.1186/s13075-014-0463-7",
language = "English (US)",
volume = "16",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - OMERACT-based fibromyalgia symptom subgroups

T2 - An exploratory cluster analysis

AU - Vincent, Ann

AU - Hoskin, Tanya L.

AU - Whipple, Mary O.

AU - Clauw, Daniel J.

AU - Barton, Debra L.

AU - Benzo, Roberto P

AU - Williams, David A.

PY - 2014

Y1 - 2014

N2 - Introduction: The aim of this study was to identify subsets of patients with fibromyalgia with similar symptom profiles using the Outcome Measures in Rheumatology (OMERACT) core symptom domains. Methods: Female patients with a diagnosis of fibromyalgia and currently meeting fibromyalgia research survey criteria completed the Brief Pain Inventory, the 30-item Profile of Mood States, the Medical Outcomes Sleep Scale, the Multidimensional Fatigue Inventory, the Multiple Ability Self-Report Questionnaire, the Fibromyalgia Impact Questionnaire-Revised (FIQ-R) and the Short Form-36 between 1 June 2011 and 31 October 2011. Hierarchical agglomerative clustering was used to identify subgroups of patients with similar symptom profiles. To validate the results from this sample, hierarchical agglomerative clustering was repeated in an external sample of female patients with fibromyalgia with similar inclusion criteria. Results: A total of 581 females with a mean age of 55.1 (range, 20.1 to 90.2) years were included. A four-cluster solution best fit the data, and each clustering variable differed significantly (P <0.0001) among the four clusters. The four clusters divided the sample into severity levels: Cluster 1 reflects the lowest average levels across all symptoms, and cluster 4 reflects the highest average levels. Clusters 2 and 3 capture moderate symptoms levels. Clusters 2 and 3 differed mainly in profiles of anxiety and depression, with Cluster 2 having lower levels of depression and anxiety than Cluster 3, despite higher levels of pain. The results of the cluster analysis of the external sample (n = 478) looked very similar to those found in the original cluster analysis, except for a slight difference in sleep problems. This was despite having patients in the validation sample who were significantly younger (P <0.0001) and had more severe symptoms (higher FIQ-R total scores (P = 0.0004)). Conclusions: In our study, we incorporated core OMERACT symptom domains, which allowed for clustering based on a comprehensive symptom profile. Although our exploratory cluster solution needs confirmation in a longitudinal study, this approach could provide a rationale to support the study of individualized clinical evaluation and intervention.

AB - Introduction: The aim of this study was to identify subsets of patients with fibromyalgia with similar symptom profiles using the Outcome Measures in Rheumatology (OMERACT) core symptom domains. Methods: Female patients with a diagnosis of fibromyalgia and currently meeting fibromyalgia research survey criteria completed the Brief Pain Inventory, the 30-item Profile of Mood States, the Medical Outcomes Sleep Scale, the Multidimensional Fatigue Inventory, the Multiple Ability Self-Report Questionnaire, the Fibromyalgia Impact Questionnaire-Revised (FIQ-R) and the Short Form-36 between 1 June 2011 and 31 October 2011. Hierarchical agglomerative clustering was used to identify subgroups of patients with similar symptom profiles. To validate the results from this sample, hierarchical agglomerative clustering was repeated in an external sample of female patients with fibromyalgia with similar inclusion criteria. Results: A total of 581 females with a mean age of 55.1 (range, 20.1 to 90.2) years were included. A four-cluster solution best fit the data, and each clustering variable differed significantly (P <0.0001) among the four clusters. The four clusters divided the sample into severity levels: Cluster 1 reflects the lowest average levels across all symptoms, and cluster 4 reflects the highest average levels. Clusters 2 and 3 capture moderate symptoms levels. Clusters 2 and 3 differed mainly in profiles of anxiety and depression, with Cluster 2 having lower levels of depression and anxiety than Cluster 3, despite higher levels of pain. The results of the cluster analysis of the external sample (n = 478) looked very similar to those found in the original cluster analysis, except for a slight difference in sleep problems. This was despite having patients in the validation sample who were significantly younger (P <0.0001) and had more severe symptoms (higher FIQ-R total scores (P = 0.0004)). Conclusions: In our study, we incorporated core OMERACT symptom domains, which allowed for clustering based on a comprehensive symptom profile. Although our exploratory cluster solution needs confirmation in a longitudinal study, this approach could provide a rationale to support the study of individualized clinical evaluation and intervention.

UR - http://www.scopus.com/inward/record.url?scp=84989227418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989227418&partnerID=8YFLogxK

U2 - 10.1186/s13075-014-0463-7

DO - 10.1186/s13075-014-0463-7

M3 - Article

C2 - 25318839

AN - SCOPUS:84989227418

VL - 16

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 1

M1 - 463

ER -